Presentation TCT 2017 TCT 48: Potential Intraplaque Hemorrhage Pattern Assessed by Combined Intravascular Ultrasound and Optical Coherence Tomography Presenter: John McB. Hodgson, Akiko Maehara, Tetsumin Lee, MD October 31, 2017
Presentation TCT 2017 TCT 72: Computational Fractional Flow Reserve Derived From Three-Dimensional Intravascular Ultrasound: A New Algorithm of Fusion Between Anatomy and Physiology Presenter: Nick Curzen, William F. Fearon, Cristiano Bezerra, MD October 31, 2017
Presentation TCT 2017 TCT 44: Frequency and Impact of Acute Stent Deformation After PCI of Left Main Coronary Artery Disease: An EXCEL Trial Intravascular Ultrasound Substudy Presenter: Ulf Landmesser, Bernhard Witzenbichler, Song-Yi Kim, MD October 31, 2017
Presentation TCT 2017 TCT 41: Initial Pre-clinical Porcine and Ex-Vivo Human Coronary Images With a Hybrid Intravascular Ultrasound and Optical Coherence Tomography System Presenter: Ulf Landmesser, Bernhard Witzenbichler, Brian Courtney, MD October 31, 2017
Presentation TCT 2017 Intravascular Ultrasound Plays an Important Role to Improve Long-term Results After Endovascular Intervention Presenter: Masato Nakamura, Shigeru Saito, Yoshimitsu Soga October 29, 2017
News Daily News Excluded From Trials, Patients With Severe Kidney Disease Benefit Less From TAVR Shelley Wood October 10, 2017
News Daily News Full Metal Jacket Approach Yields ‘Acceptable’ Long-term Outcomes in CTOs Yael L. Maxwell June 30, 2017
News Features How Low Can You Go? Concerns Over Aggressive LDL Lowering Eased as PCSK9 Evidence Mounts Michael O'Riordan May 23, 2017
News Conference News EuroPCR 2017 No Very Late Scaffold Thrombosis Risk With Absorb BVS Studies in China, Japan Michael O'Riordan May 17, 2017
News Features Absorb in Europe: When, How, and by Whom the Beleaguered BVS Is Being Used After Restrictions Michael O'Riordan May 08, 2017
News Daily News Scaffold Thrombosis Concerns With Absorb BVS Echoed in AIDA Trial Michael O'Riordan March 29, 2017
News Conference News ACC 2017 ABSORB III: Two-Year Results Show a Higher MACE Rate Compared With Xience Michael O'Riordan March 18, 2017